Who Buys Hydrochlorothiazide from India — 1130 Importers Behind a $406.8M Market
India's hydrochlorothiazide import market is served by 1130 active buyers who collectively imported $406.8M across 6,947 shipments. UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES) leads with a 34.5% market share, followed by PHARMASCIENCE INC. and UNICHEM PHARMACEUTICALS (USA) INC. The top 5 buyers together control 64.9% of total import value, reflecting a concentrated buyer landscape.
Top Hydrochlorothiazide Importers — Ranked by Import Value
UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES) is the leading hydrochlorothiazide importer from India, holding a 34.5% share of the $406.8M market across 6,947 shipments from 1130 buyers. The top 5 buyers — UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES), PHARMASCIENCE INC. (CANADA), UNICHEM PHARMACEUTICALS (USA) INC (UNITED STATES), MACLEODS PHARMA USA,INC (UNITED STATES), UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES) — collectively control 64.9% of total import value.
Top Hydrochlorothiazide Buyers & Importers
Ranked by import value · 1130 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | UNICHEM PHARMACEUTICALS (USA) INC..UNITED STATES | $140.5M | 5 | 34.5% |
| 2 | PHARMASCIENCE INC.CANADA HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000THYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100TRAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS | $59.0M | 5 | 14.5% |
| 3 | UNICHEM PHARMACEUTICALS (USA) INCUNITED STATES | $23.2M | 5 | 5.7% |
| 4 | MACLEODS PHARMA USA,INCUNITED STATES CARDIZ CO 40/12.5MG INNOVAT_ZAZHTZWISE 25 (HYDROCHLOROTHIAZIDE TABLETS | $21.0M | 5 | 5.2% |
| 5 | UNICHEM PHARMACEUTICALS (USA) INC.UNITED STATES | $20.1M | 5 | 5.0% |
| 6 | MACLEODS PHARMA USA ,INCUNITED STATES CARDIZ CO 40/12.5MG INNOVAT_ZAZHTZWISE 25 (HYDROCHLOROTHIAZIDE TABLETS | $11.9M | 5 | 2.9% |
| 7 | CSP VIATRIS SANTE AT CSP- LAB,FRANCE IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 1IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN 300 | $5.8M | 5 | 1.4% |
| 8 | MACLEODS PHARMA USA,INC,UNITED STATES CARDIZ CO 40/12.5MG INNOVAT_ZAZHTZWISE 25 (HYDROCHLOROTHIAZIDE TABLETS | $5.4M | 5 | 1.3% |
| 9 | NORVIK ENTERPRISES LIMITEDUGANDA ARISTO TELVAS H 80/12.5ARISTO TELVAS H 40/12.5AMLOZAAR H TAX IN | $5.0M | 5 | 1.2% |
| 10 | MYLAN PHARMACEUTICALS INCUNITED STATES IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 1 | $4.6M | 5 | 1.1% |
| 11 | MACLEODS PHARMA USA INCUNITED STATES CARDIZ CO 40/12.5MG INNOVAT_ZAZHTZWISE 25 (HYDROCHLOROTHIAZIDE TABLETS | $3.9M | 5 | 1.0% |
| 12 | NUEVOS ETICOS NEOETHICALS, S.A.GUATEMALA AMILORIDE HCL+HYDROCHLOROTHIAZIDE 5MG+50(HYDROCHLOROTHIAZIDE TABLETS BP 50MG | $3.3M | 5 | 0.8% |
| 13 | M/S. MYLAN PHARMACEUTICALS INC,UNITED STATES HYDROCHLOROTHIAZIDE TABLETS USP 25MG BOTTLE OF 1000THYDROCHLOROTHIAZIDE 50MG TAB - 100T BOTTLE OF 100TVALSARTAN AND HYDROCHLOROTHIAZIDE TABLET | $2.7M | 5 | 0.7% |
| 14 | UNICHEM PHARMACEUTICALS USA INCUNITED STATES | $2.6M | 5 | 0.6% |
| 15 | MYLAN PHARMACEUTICALS INC,UNITED STATES IRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 3VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETIRBESARTAN / HYDROCHLOROTHIAZIDE MYLAN 1 | $2.3M | 5 | 0.6% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Hydrochlorothiazide — and from which countries?
Flow of Hydrochlorothiazide exports from India: each country's share and the named importers behind the numbers
Hydrochlorothiazide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $258.7M through 858 shipments. This represents a market share of 63.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• UNICHEM PHARMACEUTICALS (USA) INC.. - $140.5M (54.3% of country's total business)
• UNICHEM PHARMACEUTICALS (USA) INC - $23.2M (9.0% of country's total business)
• MACLEODS PHARMA USA,INC - $21.0M (8.1% of country's total business)
• UNICHEM PHARMACEUTICALS (USA) INC. - $20.1M (7.8% of country's total business)
• MACLEODS PHARMA USA ,INC - $11.9M (4.6% of country's total business)
• Rest of United States's importers - $41.9M (16.2% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $301.5K, indicating premium pricing strategy compared to the market average of $58.6K.
United States is a key market for Hydrochlorothiazide imports, representing 63.6% of total trade value.
2Canada
Canada emerges as the second largest importing country, achieving a total trade value of $60.8M through 9 shipments. This represents a market share of 14.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• PHARMASCIENCE INC. - $59.0M (97.1% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $6.8M, indicating premium pricing strategy compared to the market average of $58.6K.
Canada is a key market for Hydrochlorothiazide imports, representing 14.9% of total trade value.
3France
France emerges as the third largest importing country, achieving a total trade value of $17.1M through 63 shipments. This represents a market share of 4.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• CSP VIATRIS SANTE AT CSP- LAB, - $5.8M (33.8% of country's total business)
• CSP MYLAN SAS AT CSP LABO 274 - $2.0M (11.5% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $272.1K, indicating premium pricing strategy compared to the market average of $58.6K.
France is a key market for Hydrochlorothiazide imports, representing 4.2% of total trade value.
4Uganda
Uganda emerges as the fourth largest importing country, achieving a total trade value of $6.7M through 62 shipments. This represents a market share of 1.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Uganda has a diverse importer base, with their top importers including:
• NORVIK ENTERPRISES LIMITED - $5.0M (74.9% of country's total business)
Key Insight: Uganda demonstrates strong market positioning with an average shipment value of $108.4K, indicating premium pricing strategy compared to the market average of $58.6K.
Uganda is a key market for Hydrochlorothiazide imports, representing 1.7% of total trade value.
5Germany
Germany emerges as the fifth largest importing country, achieving a total trade value of $5.6M through 0 shipments. This represents a market share of 1.4% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $5.6M, indicating premium pricing strategy compared to the market average of $58.6K.
Germany is a key market for Hydrochlorothiazide imports, representing 1.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Hydrochlorothiazide buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Hydrochlorothiazide imported from India encompasses several key segments:
1. Pharmaceutical Distributors: Entities like UNICHEM PHARMACEUTICALS (USA) INC. and PHARMASCIENCE INC. (Canada) fall into this category. They procure large volumes to supply to various healthcare providers, pharmacies, and hospitals. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.
2. Contract Manufacturers: Companies such as MACLEODS PHARMA USA, INC. and MYLAN PHARMACEUTICALS INC. operate in this segment. They import Hydrochlorothiazide as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and market demand forecasts.
3. Government Procurement Agencies: Organizations like CSP VIATRIS SANTE in France and NORVIK ENTERPRISES LIMITED in Uganda represent this segment. They purchase Hydrochlorothiazide for national healthcare programs, often through tender-based systems to ensure cost-effectiveness and broad access. Their buying behavior is influenced by public health policies and budget allocations.
Country-Specific Import Regulations
TransData Nexus Hydrochlorothiazide buyer market intelligence
1Country-Specific Import Regulations
Importing Hydrochlorothiazide into the top five countries involves adherence to specific regulatory frameworks:
1. United States:
2. Canada:
3. France:
4. Uganda:
5. Germany:
Demand Drivers & Market Opportunity
TransData Nexus Hydrochlorothiazide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Hydrochlorothiazide in importing countries is driven by several factors:
1. Disease Prevalence: Hypertension is a leading risk factor for cardiovascular diseases globally. The World Health Organization (WHO) reports that approximately 1.13 billion people worldwide have hypertension, with a significant proportion in low- and middle-income countries. This high prevalence necessitates effective management strategies, including the use of medications like Hydrochlorothiazide.
2. Government Healthcare Programs: Many countries have implemented national health programs targeting non-communicable diseases. For instance, the WHO's "Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020" emphasizes the importance of access to essential medicines for managing conditions like hypertension. Such programs often involve bulk procurement of medications, creating substantial market opportunities.
3. Universal Health Coverage Expansion: The global push towards Universal Health Coverage (UHC) aims to provide all individuals with access to necessary health services without financial hardship. This includes ensuring the availability of essential medicines, thereby increasing the demand for affordable options like Hydrochlorothiazide.
4. WHO Essential Medicines List Procurement: Hydrochlorothiazide is listed on the WHO Model List of Essential Medicines, indicating its critical role in a basic health system. Countries often prioritize the procurement of such listed medicines to meet public health needs, further driving demand.
5. Tender-Based Purchasing: Many governments and international organizations utilize tender systems for pharmaceutical procurement to ensure cost-effectiveness and transparency. Suppliers that can meet quality standards and offer competitive pricing are well-positioned to benefit from these opportunities.
Given the extensive buyer base of 1,130 across 149 countries, the market for Hydrochlorothiazide remains robust. Suppliers that align with regulatory requirements and effectively engage with the various buyer segments can capitalize on the sustained demand for this essential medication.
Common Questions — Hydrochlorothiazide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest hydrochlorothiazide buyer importing from India?
Based on import volume and value, UNICHEM PHARMACEUTICALS (USA) INC.. (UNITED STATES) leads with $140.5M in imports and a 34.5% market share — the highest of any single hydrochlorothiazide importer. PHARMASCIENCE INC. (CANADA) and UNICHEM PHARMACEUTICALS (USA) INC (UNITED STATES) are the next largest buyers.
QHow many companies buy hydrochlorothiazide from India?
There are 1130 active hydrochlorothiazide buyers importing from India, with a combined market of $406.8M across 6,947 shipments to 149 countries. The top 5 buyers hold 64.9% of total import value, while the remaining 1125 buyers handle the other 35.1%.
QWhich countries import the most hydrochlorothiazide from India?
The top importing countries for hydrochlorothiazide from India are United States (63.6%), Canada (14.9%), France (4.2%), Uganda (1.7%), Germany (1.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of hydrochlorothiazide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for hydrochlorothiazide from India?
The average import transaction value for hydrochlorothiazide from India is $58.6K, with an average unit price of $7.00 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Hydrochlorothiazide buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Hydrochlorothiazide imported from India encompasses several key segments:
1. Pharmaceutical Distributors: Entities like UNICHEM PHARMACEUTICALS (USA) INC. and PHARMASCIENCE INC. (Canada) fall into this category. They procure large volumes to supply to various healthcare providers, pharmacies, and hospitals. Their purchasing behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.
2. Contract Manufacturers: Companies such as MACLEODS PHARMA USA, INC. and MYLAN PHARMACEUTICALS INC. operate in this segment. They import Hydrochlorothiazide as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules and market demand forecasts.
3. Government Procurement Agencies: Organizations like CSP VIATRIS SANTE in France and NORVIK ENTERPRISES LIMITED in Uganda represent this segment. They purchase Hydrochlorothiazide for national healthcare programs, often through tender-based systems to ensure cost-effectiveness and broad access. Their buying behavior is influenced by public health policies and budget allocations.
Country-Specific Import Regulations
TransData Nexus Hydrochlorothiazide buyer market intelligence
1Country-Specific Import Regulations
Importing Hydrochlorothiazide into the top five countries involves adherence to specific regulatory frameworks:
1. United States:
2. Canada:
3. France:
4. Uganda:
5. Germany:
Demand Drivers & Market Opportunity
TransData Nexus Hydrochlorothiazide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Hydrochlorothiazide in importing countries is driven by several factors:
1. Disease Prevalence: Hypertension is a leading risk factor for cardiovascular diseases globally. The World Health Organization (WHO) reports that approximately 1.13 billion people worldwide have hypertension, with a significant proportion in low- and middle-income countries. This high prevalence necessitates effective management strategies, including the use of medications like Hydrochlorothiazide.
2. Government Healthcare Programs: Many countries have implemented national health programs targeting non-communicable diseases. For instance, the WHO's "Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020" emphasizes the importance of access to essential medicines for managing conditions like hypertension. Such programs often involve bulk procurement of medications, creating substantial market opportunities.
3. Universal Health Coverage Expansion: The global push towards Universal Health Coverage (UHC) aims to provide all individuals with access to necessary health services without financial hardship. This includes ensuring the availability of essential medicines, thereby increasing the demand for affordable options like Hydrochlorothiazide.
4. WHO Essential Medicines List Procurement: Hydrochlorothiazide is listed on the WHO Model List of Essential Medicines, indicating its critical role in a basic health system. Countries often prioritize the procurement of such listed medicines to meet public health needs, further driving demand.
5. Tender-Based Purchasing: Many governments and international organizations utilize tender systems for pharmaceutical procurement to ensure cost-effectiveness and transparency. Suppliers that can meet quality standards and offer competitive pricing are well-positioned to benefit from these opportunities.
Given the extensive buyer base of 1,130 across 149 countries, the market for Hydrochlorothiazide remains robust. Suppliers that align with regulatory requirements and effectively engage with the various buyer segments can capitalize on the sustained demand for this essential medication.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1130 global importers of Hydrochlorothiazide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 6,947 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 149 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,947 Verified Shipments
1130 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists